Regarding the neuroprotective effects of insulin in the brain,7 and the probable causative role of insulin resistance in PD pathogenesis,8 emerging studies continue to demonstrate the beneficial effects of intranasal (IN) insulin in both animal models of PD and humans in clinical trials.9, 10, 11. This evidence concerns the gene INS and Parkinson disease.